Answers are grounded in this paper and cite their sources.
Zn-0.4 Sr and Zn-0.8 Sr (wt.%) alloys (denoted ZS0.4 and ZS0.8) were processed by a single-pass friction stir processing (FSP) using a non-shouldered spiral tool (10 mm diameter, 2° tilt angle) at 1300 rpm, 200 mm/min traverse speed, and ~1 mm plunge depth at room temperature. Mechanical properties were evaluated using tensile testing, nanoindentation, and Vickers and Brinell hardness measurements. Corrosion and degradation behaviors were assessed via electrochemical polarization and 30-day immersion in Hanks' solution and DMEM+FBS. Tribocorrosion resistance was examined by reciprocating friction tests under dry conditions and in liquid-wetted environments of Hanks' solution and DMEM+FBS. Biological performance was assessed using MC3T3-E1, MG-63, and hBMSC cultures, along with a rat subcutaneous implantation model. The horizontally tested ZS0.8 exhibited an exceptional strength-elongation product of 4.1 GPa%, with an ultimate tensile strength of 258 MPa, a yield strength of 210 MPa, an elongation of 15.9%, and a nanoindentation hardness of 2.6 GPa for the SrZn 13 phase, compared with 0.7 GPa for the α-Zn matrix. Electrochemical corrosion rates of ZS0.8 were 388 μm/y in Hanks' and 216 μm/y in DMEM+FBS, while 30-day degradation rates were 44.9 μm/y and 27.2 μm/y, respectively. ZS0.8 also exhibited superior tribocorrosion resistance. Biologically, 25% and 50% extracts of ZS0.8 enhanced MC3T3-E1 and MG-63 viability, promoted hBMSC osteogenic differentiation and mineralization, showed potent anti- Staphylococcus aureus activity both in vitro and in vivo, and maintained good biosafety. These findings demonstrate a favorable balance of mechanical, degradation, and biological properties for load-bearing bone-fixation applications.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: